Evexia is excited to announce that ELISA/ACT Biotechnologies testing is now available to our clients through the EvexiaLink test menu.

ELISA/ACT Biotechnologies (EAB) is the exclusive provider of the Lymphocyte Response Assay (LRA) by ELISA/ACT tests – the gold standard in delayed hypersensitivity testing.

Built on a strong foundation of patented technology, patient-friendly guidance, value-added support, and proven results, EAB will provide you with a successful plan to determine and address the causes of chronic disease and immune system dysfunction and restore overall health.

For over 30 years, our clinically proven, proprietary tests and individualized treatment plans have been used successfully in managing chronic autoimmune and immune dysfunction syndromes.